This scientific article addresses a growing and serious problem that threatens global public health, namely antimicrobial resistance (AMR) and multidrug-resistant bacteria (MDR). Statistics suggest that this problem could cause 10 million deaths per year by 2050 if effective solutions are not developed. Conventional antibiotics are increasingly failing to treat this infection due to the bacteria"s sophisticated resistance mechanisms, such as the formation of biofilms that protect them, the secretion of antibiotic-disrupting enzymes, and the use of Efflux pumps to expel the antibiotic out of the cell.
The article reviews the innovative solutions offered by the field of nanotherapeutics to combat these challenges. This technology not only improves the delivery of conventional medicines, but also goes beyond designing smart platforms that can overcome bacterial resistance mechanisms in multiple ways:
Nano delivery Platforms: The use of nanoparticles (such as polymers or lipids) to carry antibiotics, protecting them from degradation, improving their penetration into bacterial biofilms, and prolonging their stay at the site of infection.
Smart Targeting: The design of nanovectors to selectively target bacteria (via passive or active targeting) or to release their load from the drug in response to specific signals in the infection environment (e.g., pH), increasing efficacy and reducing side effects.
Innovative Mechanisms: Use advanced strategies such as "nanodecoys" that mimic human cell receptors to trick and bind bacteria, or modulate the body"s immune response to fight infection more effectively.
Synergistic Effect: Combining nanoparticles (such as metals) with conventional antibiotics to enhance their bacteria-killing effect across multiple and sequential mechanisms of action.